Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pLenti6-PSMA6 (#RDB15486)

Rentiviral expression vector of human proteasome subunit alpha 6 (PSMA6), tagged with V5-tag at C-terminal.

Clone info. Rentiviral expression vector of human proteasome subunit alpha 6 (PSMA6), tagged with V5-tag at C-terminal.
Comment Expression was confirmed by the depositor with western blot.
Vector backbone pLenti6/V5-GW/lacZ (Plasmid)
Selectable markers Amp^r (E. coli), Bsd^r (mammalian cells).
Gene/insert name Human PSMA6 cDNA
Depositor|Developer Sato, Mitsuo |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Approval form by depositor [Word]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested (Kakumu, T et al., Cancer Sci. 108, 732-743. 2017). RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR.
Remarks ((Additional form)) Approval Form(FormD)
Please obtain written approval of the depositor.
Gateway® Expression clone. Please refer Life Technologies Corporation signs license agreement with RIKEN BRC.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
寄託者による提供承諾書 [Word]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 １．利用者は提供承諾書を用いて、事前に寄託者の承諾を得る。2. 利用者は、研究成果の公表にあたって開発者の指定する文献を引用する（Kakumu, T et al., Cancer Sci. 108, 732-743. 2017）。3. 寄託者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。4. 営利機関の利用希望者は、事前に利用条件等につき寄託者と合意し、提供承諾を得ること。
備考 【追加提供依頼書】承諾書(FormD)
寄託者の書面による提供承諾が必要です。
Gateway®テクノロジーを用いた発現クローンです。「Gateway®テクノロジーを用いたクローンの提供と寄託のご案内」をご覧ください。

Catalog # Resource name Availability Shipping form Fee (non-profit org.)
RDB15486 pLenti6-PSMA6 Under QC test. Please contact us. DNA solution JPY 9,460 (not-for-profit academic purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge plus licensing fee equivalent for Gateway® expression clone

check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.

How to cite this biological resource

Materials & Methods section:

The pLenti6-PSMA6 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB15486).

Reference section:

Kakumu, T., Sato, M., Goto, D., Kato, T., Yogo, N., Hase, T., Morise, M., Fukui, T., Yokoi, K., Sekido, Y., Girard, L., Minna, J.D., Byers, L.A., Heymach, J.V., Coombes, K.R., Kondo, M., Hasegawa, Y., Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. Cancer Sci. 108 (4): 732-743 (2017). PMID 28165654. [link to RRC of NBRP]

Further references such as user reports and related articles (go to bottom)

QC test results

check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.

References

Original, user report and related articles

original Kakumu, T., Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. Cancer Sci. 108 (4): 732-743 (2017). PMID 28165654. [link to RRC of NBRP]